| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,922 |
7,247 |
$1.25M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
693 |
666 |
$118K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
394 |
388 |
$68K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
246 |
243 |
$39K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
165 |
161 |
$32K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
84 |
75 |
$15K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
58 |
53 |
$7K |
| 99384 |
|
19 |
19 |
$4K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
1,006 |
812 |
$2K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,011 |
973 |
$185.57 |
| 81003 |
|
237 |
226 |
$2.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
145 |
141 |
$0.00 |
| 90461 |
|
504 |
489 |
$0.00 |
| 90633 |
|
28 |
28 |
$0.00 |
| 90715 |
|
47 |
47 |
$0.00 |
| 90734 |
|
43 |
39 |
$0.00 |
| 90686 |
|
280 |
276 |
$0.00 |
| 90651 |
|
96 |
96 |
$0.00 |
| 90619 |
|
93 |
92 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
12 |
12 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
38 |
38 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
12 |
12 |
$0.00 |
| 90620 |
|
15 |
15 |
$0.00 |